On September 29, the Impact Speaker Series presents Russell Medford, M.D., Ph.D., founder of an Atlanta-based biomedical company. The Impact Speaker Series features entrepreneurs, founders and executives of high-tech and biotechnology companies who have made a significant impact in their industry. The technology community is invited to network, learn and ask questions of these successful entrepreneurs. The Impact Speaker series is sponsored by Georgia Tech's DuPree College of Management and the College of Engineering. The Impact Speaker Series is free and open to the public and takes place on the Georgia Tech campus in the Wardlaw Building, located on North Avenue at the corner of Techwood Drive.
Parking is available under the building.
This has positioned the company to continue its research and development activities, including clinical trials for promising drug candidates. Dr. Medford, a molecular biologist and cardiologist, and R. Wayne Alexander, M.D., Ph.D., founded the company in 1993 based on their discoveries made at Emory University laboratories. N.Y. Prior to founding AtheroGenics, Dr. Medford held a number of academic appointments at Emory University and served on the faculty of Medicine at Harvard Medical School. Helios Health Inc. The Program for Engineering Entrepreneurship is a collaborative effort between Georgia Tech's DuPree College of Management and the College of Engineering offering learning opportunities for the Georgia Tech and Atlanta community focusing on developing the skills and attitudes necessary to meet the challenges of high-tech entrepreneurship. The Program provides opportunities for learning through the Impact Speaker Series featuring high profile company founders and CEOs, short courses in entrepreneurship, academic conferences, and classes.